Ref. or Acc. number | Symbol | Gene name | TNBS/Con(mean ± SD) |
---|---|---|---|
Channels | |||
AY323810 | Cacna1c | calcium channel, voltage-dependent, L type, alpha 1C subunit | 18.45 ± 1.62 |
NM_019294 | Cacna1e | calcium channel, voltage-dependent, L type, alpha 1E subunit | 14.82 ± 1.51 |
XM_341818 | Ryr1 | ryanodine receptor 1, skeletal muscle | 13.50 ± 1.23 |
NM_012825 | Aqp4 | aquaporin 4 | 10.26 ± 1.21 |
NM_019256 | P2rx7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 3.75 ± 0.81 |
XM_233477 | Kcnq4 | potassium voltage-gated channel, subfamily Q, member 4 | 3.03 ± 0.57 |
XM_344426 | Kctd9 | potassium channel tetramerisation domain containing 9 | 2.76 ± 0.32 |
NM_017261 | Gria2 | glutamate receptor, ionotropic, AMPA2 | 2.47 ± 0.29 |
NM_017303 | Kcnab1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | 2.25 ± 0.27 |
NM_031046 | Itpr2 | inositol 1,4,5-triphosphate receptor 2 | 2.17 ± 0.25 |
AI407979 | Fxyd5 | FXYD domain-containing ion transport regulator 5 | 0.46 ± 0.04 |
NM_053870 | Kcnj4 | potassium inwardly-rectifying channel, subfamily J, member 4 | 0.44 ± 0.05 |
AF313481 | Trpc3 | transient receptor potential cation channel, subfamily C, member 3 | 0.27 ± 0.04 |
Receptor | |||
NM_012585 | Htr1a | 5-hydroxytryptamine (serotonin) receptor 1A | 9.87 ± 1.32 |
NM_012675 | Tnf | tumor necrosis factor (TNF superfamily, member 2) | 8.94 ± 1.21 |
M64867 | Htr2a | 5-hydroxytryptamine (serotonin) receptor 2A | 5.12 ± 0.98 |
NM_053429 | Fgfr3 | fibroblast growth factor receptor 3 | 4.81 ± 0.84 |
NM_001002853 | P2ry13 | purinergic receptor P2Y, G-protein coupled, 13 | 2.92 ± 0.45 |
BC087035 | Tgfbr1 | transforming growth factor, beta receptor 1 | 2.68 ± 0.46 |
NM_001013032 | Npy1r | neuropeptide Y receptor Y1 | 2.31 ± 0.30 |
NM_031569 | Oprl1 | opioid receptor-like 1 | 2.26 ± 0.23 |
NM_031088 | Ptger2 | prostaglandin E receptor 2, subtype EP2 | 2.26 ± 0.25 |
NM_053552 | Tnfsf4 | tumor necrosis factor (ligand) superfamily, member 4 | 2.15 ± 0.14 |
NM_012800 | P2ry1 | purinergic receptor P2Y, G-protein coupled 1 | 2.10 ± 0.10 |
XM_217136 | Cd3g | CD3 antigen, gamma polypeptide | 0.47 ± 0.05 |
NM_019198 | Fgf17 | fibroblast growth factor 17 | 0.42 ± 0.06 |
NM_138880 | Ifng | interferon gamma | 0.36 ± 0.04 |
NM_053680 | Insl3 | insulin-like 3 | 0.02 ± 0.01 |
Signal transduction-related molecules | |||
AW526572 | RragB | Ras-related GTP binding B | 12.28 ± 1.89 |
XM_220933 | Arf4l | ADP-ribosylation factor 4-like | 6.06 ± 0.64 |
XM_343450 | Rasa2 | RAS p21 protein activator 2 | 4.44 ± 0.41 |
NM_133392 | Stk17b | serine/threonine kinase 17b (apoptosis-inducing) | 3.13 ± 0.30 |
NM_031622 | Mapk6 | mitogen-activated protein kinase 6 (ERK 3) | 3.00 ± 0.34 |
XM_236242 | Rab39 | RAB39, member RAS oncogene family | 2.73 ± 0.31 |
NM_134346 | Rap1b | RAS related protein 1b | 2.69 ± 0.36 |
NM_031130 | Nr2f1 | nuclear receptor subfamily 2, group F, member 1 | 2.59 ± 0.29 |
XM_342223 | Prkci | protein kinase C, iota | 2.46 ± 0.26 |
NM_022692 | Rab5a | RAB5A, member RAS oncogene family | 2.36 ± 0.26 |
XM_225020 | Rasa3 | RAS p21 protein activator 3 | 2.34 ± 0.24 |
XM_341399 | Mapk8 | mitogen-activated protein kinase 8 (JNK 1) | 2.33 ± 0.28 |
NM_053522 | Rhoq | ras homolog gene family, member Q | 2.19 ± 0.18 |
M83679 | Rab15 | RAB15, member RAS onocogene family | 2.17 ± 0.16 |
NM_021763 | Arfip1 | ADP-ribosylation factor interacting protein 1 | 2.14 ± 0.14 |
NM_053306 | Pak2 | p21 (CDKN1A)-activated kinase 2 | 2.07 ± 0.10 |
XM_232732 | Map3k6 | mitogen-activated protein kinase kinase kinase 6 | 0.49 ± 0.04 |
BF403410 | Camk2b | Calcium/calmodulin-dependent protein kinase II, beta | 0.46 ± 0.04 |
NM_031716 | Wisp1 | WNT1 inducible signaling pathway protein 1 | 0.45 ± 0.04 |
NM_133568 | Rasd2 | RASD family, member 2 | 0.38 ± 0.05 |
XM_215821 | Usp8 | ubiquitin specific protease 8 | 0.36 ± 0.04 |
AA945841 | Rab10 | RAB10, member RAS oncogene family | 0.33 ± 0.05 |